The results of CK19 immunohistochemistry, TC, and evaluation of cholestasis-related indicators showed that the intervention of SHCZF and UDCA effectively improved the bile duct dilatation and cholestasis in the rat liver. The gene discussed is KRT19; the disease is cholestasis.